FoundationOne CDx Test and Its Cost

FoundationOne CDx is a laboratory test that analyzes the DNA of a patient's tumor to identify genetic alterations that may be driving cancer. It is a type of comprehensive genomic profiling test that uses next-generation sequencing technology to analyze the entire coding sequence of cancer-related genes. It helps in identifying whether the patient has a specific type of gene mutation that is targeted by specific therapy or medication and also whether the medication or therapy is working effectively or not.

The test looks for a variety of alterations, including single nucleotide variants, insertions and deletions, copy number alterations, and rearrangements. It can detect alterations in more than 300 cancer-related genes, including those that are well-established targets for existing therapies, as well as emerging targets that may be relevant for future treatments.

This test is used for the diagnosis of solid tumors and the results of the test can be used to guide treatment decisions, by identifying targeted therapies that may be effective against the patient's specific cancer. The test may also be used to identify patients who are eligible for clinical trials of new therapies or to determine the prognosis of the patient's cancer.

Why is FoundationOne CDx Done?

FoundationOne CDx is a widely used diagnostic test for solid tumors and guides treatment decisions for a variety of cancer types, including lung cancer, breast cancer, colorectal cancer, and melanoma, among others.

FoundationOne CDx is done to help guide treatment decisions for patients with cancer. The test analyzes the DNA of a patient's tumor to identify genetic alterations that may be driving cancer and can detect alterations in more than 300 cancer-related genes, including those that are well-established targets for existing therapies, as well as emerging targets that may be relevant for future treatments.

The test can provide valuable information about the specific genetic alterations that are present in a patient's tumor, which can help doctors identify targeted therapies that may be effective against cancer. By understanding the genetic makeup of cancer, doctors can make more informed decisions about which treatments are most likely to be effective and can avoid treatments that are unlikely to be effective.

It is particularly useful for patients who have advanced or metastatic cancer, where treatment options may be limited. By identifying genetic alterations in the tumor, doctors can identify targeted therapies that may be more effective than traditional chemotherapy or radiation therapy.

In addition to guiding treatment decisions, FoundationOne CDx can also be used to identify patients who may be eligible for clinical trials of new therapies, and to determine the prognosis of the patient's cancer. Overall, the test provides valuable information that can help improve outcomes for patients with cancer.

Sample required for FoundationOne CDx?

Tumor tissue sample

Cost of FoundationOne CDx

The Cost of FoundationOne CDx near me in Delhi ranges from INR 200000 to INR 500000